0.80
price up icon3.90%   0.03
after-market 시간 외 거래: .80
loading
전일 마감가:
$0.77
열려 있는:
$0.78
하루 거래량:
101.96K
Relative Volume:
0.45
시가총액:
$62.80M
수익:
$8.23M
순이익/손실:
$-32.49M
주가수익비율:
-1.5094
EPS:
-0.53
순현금흐름:
$-19.91M
1주 성능:
-2.49%
1개월 성능:
+5.12%
6개월 성능:
-19.58%
1년 성능:
-38.46%
1일 변동 폭
Value
$0.78
$0.80
1주일 범위
Value
$0.77
$0.84
52주 변동 폭
Value
$0.7001
$1.65

Clearside Biomedical Inc Stock (CLSD) Company Profile

Name
명칭
Clearside Biomedical Inc
Name
전화
678-270-3631
Name
주소
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Name
직원
32
Name
트위터
@clearsidebio
Name
다음 수익 날짜
2025-03-18
Name
최신 SEC 제출 서류
Name
CLSD's Discussions on Twitter

CLSD을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CLSD
Clearside Biomedical Inc
0.80 62.80M 8.23M -32.49M -19.91M -0.53
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.20 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
525.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
326.09 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
551.22 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
242.07 28.51B 3.81B -644.79M -669.77M -6.24

Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-08-21 개시 Chardan Capital Markets Buy
2024-06-25 개시 Oppenheimer Outperform
2021-12-15 재개 Wedbush Outperform
2021-07-29 개시 H.C. Wainwright Buy
2020-05-13 개시 ROTH Capital Buy
2019-08-09 다운그레이드 Needham Buy → Hold
2018-11-05 다운그레이드 Cowen Outperform → Market Perform
2018-11-05 다운그레이드 JP Morgan Overweight → Underweight
2018-11-05 다운그레이드 Stifel Buy → Hold
2018-03-06 재확인 Needham Buy
2017-05-25 개시 JMP Securities Mkt Outperform
2017-02-24 개시 JP Morgan Overweight
2016-11-10 재확인 Needham Buy
2016-10-24 재확인 Stifel Buy
모두보기

Clearside Biomedical Inc 주식(CLSD)의 최신 뉴스

pulisher
Jun 18, 2025

Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting - GlobeNewswire

Jun 18, 2025
pulisher
Jun 17, 2025

Clearside Biomedical Announces Multiple Presentations to be Feat - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting | CLSD Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

Clearside Biomedical Showcases Suprachoroidal Injection Platform for Retinal Diseases at CTS Meeting - Nasdaq

Jun 17, 2025
pulisher
Jun 16, 2025

Comprehensive Age-related Macular Degeneration Market Analysis: Trends and Developments Across All Types - GlobeNewswire Inc.

Jun 16, 2025
pulisher
Jun 10, 2025

Clearside Biomedical, Inc. (NASDAQ:CLSD) Given Consensus Recommendation of “Buy” by Brokerages - Defense World

Jun 10, 2025
pulisher
Jun 04, 2025

Northern Trust Corp Has $157,000 Holdings in Clearside Biomedical, Inc. (NASDAQ:CLSD) - Defense World

Jun 04, 2025
pulisher
May 30, 2025

Clearside Biomedical Approves Share Increase at Annual Meeting - TipRanks

May 30, 2025
pulisher
May 30, 2025

Clearside Biomedical (CLSD) Upgraded to Buy: Here's What You Should Know - MSN

May 30, 2025
pulisher
May 28, 2025

Clearside Biomedical (CLSD) Gets a Buy from H.C. Wainwright - The Globe and Mail

May 28, 2025
pulisher
May 27, 2025

Clearside Biomedical’s SWOT analysis: eye disease stock faces funding hurdles amid promising pipeline - Investing.com India

May 27, 2025
pulisher
May 27, 2025

Clearside Biomedical target cut to $5 by H.C. Wainwright - Investing.com

May 27, 2025
pulisher
May 25, 2025

HC Wainwright Lowers Clearside Biomedical (NASDAQ:CLSD) Price Target to $5.00 - Defense World

May 25, 2025
pulisher
May 23, 2025

Clearside Biomedical (CLSD) Price Target Lowered by Analyst | CL - GuruFocus

May 23, 2025
pulisher
May 23, 2025

H.C. Wainwright Adjusts Price Target for Clearside Biomedical (C - GuruFocus

May 23, 2025
pulisher
May 23, 2025

Clearside Biomedical (CLSD) Price Target Lowered by Analyst | CLSD Stock News - GuruFocus

May 23, 2025
pulisher
May 21, 2025

Clearside Biomedical to Participate in a Fireside Chat at the St - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum | CLSD Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

Clearside Biomedical Reveals Next-Gen Eye Therapy Platform at Exclusive Stifel Conference - Stock Titan

May 21, 2025
pulisher
May 19, 2025

Analysts Set Clearside Biomedical, Inc. (NASDAQ:CLSD) Price Target at $5.00 - Defense World

May 19, 2025
pulisher
May 18, 2025

JMP Securities Reiterates “Market Outperform” Rating for Clearside Biomedical (NASDAQ:CLSD) - Defense World

May 18, 2025
pulisher
May 17, 2025

Clearside Biomedical (NASDAQ:CLSD) Raised to Hold at StockNews.com - Defense World

May 17, 2025
pulisher
May 17, 2025

Needham & Company LLC Lowers Clearside Biomedical (NASDAQ:CLSD) Price Target to $3.00 - Defense World

May 17, 2025
pulisher
May 16, 2025

JMP maintains $5 target on Clearside Biomedical stock By Investing.com - Investing.com Nigeria

May 16, 2025
pulisher
May 16, 2025

Clearside Biomedical (CLSD) Reiterates Market Outperform Rating - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Clearside Biomedical Reports Q1 2025 Financial Progress - TipRanks

May 16, 2025
pulisher
May 15, 2025

Clearside Biomedical (CLSD) Target Price Lowered by Needham | CL - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Clearside Biomedical, Inc. (CLSD) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 15, 2025
pulisher
May 15, 2025

Stifel maintains Buy on Clearside Biomedical, target at $8 By Investing.com - Investing.com South Africa

May 15, 2025
pulisher
May 15, 2025

Stifel maintains Buy on Clearside Biomedical, target at $8 - Investing.com Australia

May 15, 2025
pulisher
May 15, 2025

Clearside Biomedical Inc (CLSD) Q1 2025 Earnings: EPS Matches Es - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Clearside (CLSD) Reports Strong Q1 Revenue Boost | CLSD Stock Ne - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Clearside Biomedical Inc (CLSD) Q1 2025 Earnings: EPS Matches Estimates at -$0.11, Revenue Surges to $2.3 Million, Exceeding Expectations - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Clearside Biomedical Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 14, 2025
pulisher
May 14, 2025

CLEARSIDE BIOMEDICAL Earnings Results: $CLSD Reports Quarterly Earnings - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire

May 14, 2025
pulisher
May 14, 2025

Clearside (CLSD) Reports Strong Q1 Revenue Boost | CLSD Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Clearside's Wet AMD Drug Advances to Phase 3: FDA Green Light Could Transform Eye Disease Treatment - Stock Titan

May 14, 2025
pulisher
May 13, 2025

Clearside Biomedical Inc (CLSD) Q1 2025 Earnings Report Preview: What To Expect - GuruFocus

May 13, 2025
pulisher
May 12, 2025

Clearside Biomedical (NASDAQ:CLSD) Cut to “Sell” at StockNews.com - Defense World

May 12, 2025
pulisher
May 10, 2025

Investor Network: Clearside Biomedical, Inc. to Host Earnings Call - ACCESS Newswire

May 10, 2025

Clearside Biomedical Inc (CLSD) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Clearside Biomedical Inc 주식 (CLSD) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Chong Ngai Hang Victor
Chief Medical Officer
Nov 01 '24
Buy
1.00
36,500
36,500
100,000
$20.66
price up icon 0.78%
$36.03
price up icon 0.45%
$21.28
price up icon 3.30%
$100.64
price up icon 1.16%
$106.47
price down icon 0.23%
biotechnology ONC
$242.07
price up icon 0.36%
자본화:     |  볼륨(24시간):